Brawn Biotech Limited (BOM:530207)
India · Delayed Price · Currency is INR 23.40
+0.70 (3.08%)
At close: Sep 7, 2026
Brawn Biotech Market Cap
Brawn Biotech has a market cap or net worth of 70.21 million as of September 4, 2026. Its market cap has increased by 11.75% in one year.
Market Cap
70.21M
Enterprise Value
67.40M
Revenue
172.59M
Ranking
n/a
PE Ratio
8.08
Stock Price
23.40
ChartMarket Cap Chart
Since August 11, 2005, Brawn Biotech's market cap has increased from 23.22M to 70.21M, an increase of 202.33%. That is a compound annual growth rate of 5.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 70.21M | 8.79% |
| Dec 31, 2025 | 64.54M | 0.94% |
| Dec 31, 2024 | 63.94M | -2.69% |
| Dec 26, 2023 | 65.71M | 11.17% |
| Dec 30, 2022 | 59.11M | -13.79% |
| Dec 31, 2021 | 68.56M | -6.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shamrock Industrial Company | 140.84M |
| Unjha Formulations | 137.28M |
| Norris Medicines | 136.51M |
| Beryl Drugs | 124.71M |
| Ortin Global | 122.46M |
| Emmessar Biotech & Nutrition | 118.76M |
| Ganga Pharmaceuticals | 70.94M |
| Vivanza Biosciences | 70.00M |